Christine Fox
EVP, Head of U.S. Commercial, Teva Pharmaceutical Industries Ltd.
Companies
- Teva Pharmaceutical Industries Ltd.EVP, Head of U.S. Commercial Nov 22, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Teva Pharmaceutical Industries Ltd. TEVA63,647 shares2$2.6M at $41.41Apr 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 30, 2026Sold 21,258 shares at $35.31 of Teva Pharmaceutical Industries Ltd.2
- Mar 5, 2026Sold 7,924 shares at $31.67 of Teva Pharmaceutical Industries Ltd.3
- Mar 5, 2026Exercised options 17,819 shares of Teva Pharmaceutical Industries Ltd.3
- Mar 4, 2026Sold 9,098 shares at $32.46 of Teva Pharmaceutical Industries Ltd.4
- Mar 4, 2026Exercised options 20,461 shares of Teva Pharmaceutical Industries Ltd.4
- Nov 20, 2025Sold 28,229 shares at $24.78 of Teva Pharmaceutical Industries Ltd.5
- Nov 20, 2025Exercised options 63,492 shares of Teva Pharmaceutical Industries Ltd.5
- Nov 14, 2025Sold 30,000 shares at $25.11 of Teva Pharmaceutical Industries Ltd.6
- Mar 5, 2025Sold 2,147 shares at $15.91 of Teva Pharmaceutical Industries Ltd.7
- Mar 4, 2025Sold 4,034 shares at $15.73 of Teva Pharmaceutical Industries Ltd.7
- Mar 4, 2025Exercised options 20,461 shares of Teva Pharmaceutical Industries Ltd.7
- Nov 20, 2024Sold 19,388 shares at $16.87 of Teva Pharmaceutical Industries Ltd.8
- Nov 20, 2024Exercised options 63,492 shares of Teva Pharmaceutical Industries Ltd.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 9, 2026
- 4SEC EDGARForm 4 filed Mar 6, 2026
- 5SEC EDGARForm 4 filed Nov 24, 2025
- 6SEC EDGARForm 4 filed Nov 18, 2025
- 7SEC EDGARForm 4 filed Mar 6, 2025
- 8SEC EDGARForm 4 filed Nov 21, 2024